한글목차

세계의 줄기세포 제조 시장은 2030년까지 230억 달러에 달할 전망

2023년에 135억 달러로 추정되는 세계의 줄기세포 제조 시장은 2023-2030년 CAGR 7.9%로 성장하며, 2030년에는 230억 달러에 달할 것으로 예측됩니다. 본 리포트에서 분석한 부문의 하나인 배지는 CAGR 7.7%를 기록하며, 분석 기간 종료까지 92억 달러에 달할 것으로 예측됩니다. 소모품 부문의 성장률은 분석 기간 중 CAGR 8.0%로 추정됩니다.

미국 시장은 36억 달러, 중국은 CAGR 7.4%로 성장할 것으로 예측

미국의 줄기세포 제조 시장은 2023년에 36억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2023-2030년의 분석 기간에 CAGR 7.4%로 추이하며, 2030년에는 예측 시장 규모 36억 달러에 달할 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 7.0%와 6.6%로 예측됩니다. 유럽에서는 독일이 CAGR 약 6.1%로 성장할 것으로 예측됩니다.

세계의 줄기세포 제조 시장 - 주요 동향과 촉진요인 정리

줄기세포 제조는 의료의 진보를 어떻게 지원하고 있는가?

줄기세포 제조는 치료, 연구 및 임상 적용을 위한 줄기세포의 대량 생산에 관여합니다. 줄기세포는 다양한 세포로 분화할 수 있는 능력이 있는 것으로 알려져 있으며, 재생의료, 질병 모델, 신약개발, 맞춤의료에서 중요한 역할을 하고 있습니다. 제조 공정에는 세포의 조달, 분리, 증식, 분화, 품질관리가 포함되며, 치료 및 연구에 사용할 수 있는 고순도 및 생존 가능한 줄기세포를 보장합니다. 재생의료가 계속 발전함에 따라 줄기세포 제조는 척수 손상, 신경 퇴행성 질환, 당뇨병, 심혈관 질환 등의 치료법 개발에 필수적이며, 임상시험과 상업적 치료를 모두 지원하고 있습니다.

줄기세포 제조 시장의 주요 부문은?

주요 제품 카테고리에는 줄기세포주, 배양용 메듐, 소모품, 기구가 포함되며, 배양용 메듐은 줄기세포의 생존력을 유지하고 생산 중 확장을 지원하는 중요한 역할을 하므로 가장 큰 시장 점유율을 차지하고 있습니다. 용도로는 연구개발, 임상시험, 치료용 등이 있으며, 그 중 임상시험은 다양한 만성질환 및 희귀질환에 대한 줄기세포 치료의 필요성으로 인해 중요한 부문을 차지하고 있습니다. 최종사용자에는 바이오제약기업, 연구기관, 병원, 전문 클리닉 등이 포함되며, 바이오제약기업은 새로운 줄기세포 치료제의 개발 및 상용화를 위해 대규모 생산에 투자하여 시장을 선도하고 있습니다.

줄기세포 생산은 어떻게 의료와 연구에 통합될 수 있는가?

임상 현장에서 줄기세포 생산은 혈액질환, 면역질환, 장기 손상 등의 질환을 대상으로 하는 재생치료에 필요한 세포의 양과 질을 제공하여 보다 개인화되고 효과적인 치료를 지원합니다. 연구개발에서 줄기세포는 질병 기전 연구, 약물 후보물질 스크리닝, 독성 평가에 사용되어 보다 신속하고 정확한 신약 개발 과정을 가능하게 합니다. 임상시험에서 일관된 줄기세포 생산은 규제 표준을 준수하고 환자의 안전을 보장하는 데 매우 중요하며, CAR-T 세포 치료 및 조직공학과 같은 첨단 치료법 개발을 촉진합니다. 또한 자동화, 바이오프로세스 및 냉동보존의 발전으로 줄기세포의 생산 효율성, 확장성 및 유통성이 향상되고 있습니다.

줄기세포 제조 시장의 성장을 가속하는 요인은 무엇인가?

줄기세포 제조 시장의 성장은 심혈관 질환, 신경질환, 자가면역 질환 등 다양한 질환의 미충족 의료 수요에 대한 재생 치료에 대한 수요 증가 등 여러 가지 요인에 의해 주도되고 있습니다. 세포배양 기술, 바이오리액터, 자동화 기술의 발전으로 줄기세포 생산의 확장성, 일관성, 비용 효율성이 향상되어 보다 광범위한 임상 및 상업적 적용이 가능해졌습니다. 줄기세포를 통해 환자 개개인의 프로파일에 따라 맞춤형 치료를 할 수 있는 맞춤형 의료와 표적치료에 대한 관심은 수요를 더욱 증가시키고 있습니다. 또한 생명공학 연구에 대한 투자 증가, 정부의 규제 강화, 연구 기관과 바이오 제약 기업 간의 협력 증가는 다양한 의료 응용을 위한 대규모 줄기세포 제조를 촉진하여 시장 성장에 기여하고 있습니다.

부문

제품(배양액, 소모품, 기구, 줄기세포주);용도(조사 기반, 세포·조직은행, 임상 기반)

조사 대상 기업의 예(주목 33사)

• Anterogen
• Becton, Dickinson and Company
• Bio-Rad Laboratories
• Cellular Dynamics International
• Holostem Terapie Avanzate
• Lonza Group
• Medipost
• Merck Group
• Miltenyi Biotec
• Osiris Therapeutics
• Pharmicell
• Pluristem Therapeutics
• Stemcell Technologies
• Takara Bio Group
• Thermo Fisher Scientific

목차

제1장 조사 방법

제2장 개요

• 시장 개요
• 주요 기업
• 시장 동향과 촉진요인
• 세계 시장의 전망

제3장 시장 분석

• 미국
• 캐나다
• 일본
• 중국
• 유럽
• 프랑스
• 독일
• 이탈리아
• 영국
• 기타 유럽
• 아시아태평양
• 기타 지역

제4장 경쟁

영문목차

Global Stem Cell Manufacturing Market to Reach US$23.0 Billion by 2030

The global market for Stem Cell Manufacturing estimated at US$13.5 Billion in the year 2023, is expected to reach US$23.0 Billion by 2030, growing at a CAGR of 7.9% over the analysis period 2023-2030. Culture Media, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$9.2 Billion by the end of the analysis period. Growth in the Consumables segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.6 Billion While China is Forecast to Grow at 7.4% CAGR

The Stem Cell Manufacturing market in the U.S. is estimated at US$3.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 7.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Global Stem Cell Manufacturing Market - Key Trends and Drivers Summarized

How Is Stem Cell Manufacturing Supporting Medical Advancements?

Stem cell manufacturing involves the large-scale production of stem cells for therapeutic, research, and clinical applications. Stem cells, known for their ability to develop into various cell types, play a critical role in regenerative medicine, disease modeling, drug discovery, and personalized medicine. The manufacturing process encompasses cell sourcing, isolation, expansion, differentiation, and quality control, ensuring high-purity, viable stem cells for use in treatments or studies. As regenerative medicine continues to evolve, stem cell manufacturing has become essential for developing therapies for conditions like spinal cord injuries, neurodegenerative diseases, diabetes, and cardiovascular disorders, supporting both clinical trials and commercial treatments.

What Are the Key Segments in the Stem Cell Manufacturing Market?

Key product categories include stem cell lines, culture media, consumables, and instruments, with culture media holding the largest market share due to its vital role in maintaining stem cell viability and supporting expansion during production. Applications cover research and development, clinical trials, and therapeutic use, with clinical trials representing a significant segment driven by the need for stem cell therapies to address various chronic and rare diseases. End-users include biopharmaceutical companies, research institutions, hospitals, and specialty clinics, with biopharmaceutical firms leading the market as they invest in large-scale production to develop and commercialize new stem cell-based therapies.

How Is Stem Cell Manufacturing Integrated Across Medicine and Research?

In clinical settings, stem cell manufacturing provides the necessary volume and quality of cells for regenerative therapies targeting conditions like blood disorders, immune diseases, and organ damage, supporting more personalized and effective treatments. In research and development, stem cells are used to study disease mechanisms, screen drug candidates, and evaluate toxicity, enabling faster and more accurate drug discovery processes. For clinical trials, consistent stem cell production is crucial to ensuring compliance with regulatory standards and patient safety, facilitating the development of advanced therapies like CAR-T cell treatments and tissue engineering. Additionally, advances in automation, bioprocessing, and cryopreservation have improved stem cell production efficiency, scalability, and distribution.

What Factors Are Driving the Growth in the Stem Cell Manufacturing Market?

The growth in the Stem Cell Manufacturing market is driven by several factors, including increasing demand for regenerative therapies that address unmet medical needs across various diseases, such as cardiovascular, neurological, and autoimmune disorders. Advancements in cell culture techniques, bioreactors, and automation have improved scalability, consistency, and cost-effectiveness in stem cell production, supporting broader clinical and commercial applications. The focus on personalized medicine and targeted treatments has further fueled demand, as stem cells enable customized therapies based on individual patient profiles. Additionally, rising investments in biotechnology research, supportive government regulations, and growing collaboration between research institutes and biopharma companies have contributed to market growth, encouraging large-scale stem cell manufacturing for diverse medical applications.

SCOPE OF STUDY:

The report analyzes the Stem Cell Manufacturing market in terms of US$ Million by the following Application; Product, and Geographic Regions/Countries:

Segments:

Product (Culture Media, Consumables, Instruments, Stem Cell Lines); Application (Research-based, Cell & Tissue Banking, Clinical-based)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 33 Featured) -

• Anterogen
• Becton, Dickinson and Company
• Bio-Rad Laboratories
• Cellular Dynamics International
• Holostem Terapie Avanzate
• Lonza Group
• Medipost
• Merck Group
• Miltenyi Biotec
• Osiris Therapeutics
• Pharmicell
• Pluristem Therapeutics
• Stemcell Technologies
• Takara Bio Group
• Thermo Fisher Scientific

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Stem Cell Manufacturing - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Autologous and Allogeneic Stem Cell Therapies Spurs Market Growth
  • Advancements in Bioprocessing Technologies Propel Manufacturing Capabilities
  • Expansion of Cell and Gene Therapy Expands Addressable Market
  • Growing Use of Stem Cells in Drug Development Strengthens Business Case
  • Rising Focus on Personalized Medicine Drives Adoption of Stem Cell Manufacturing
  • Increasing Use in Disease Modeling and Tissue Engineering Fuels Growth
  • Emergence of Automated Cell Culture Technologies Expands Opportunities
  • Rising Focus on Oncology and Cardiovascular Applications Spurs Adoption
  • Emergence of 3D Culture Technologies Strengthens Market Growth
  • Rising Need for Scalable Manufacturing Solutions Accelerates Demand
  • Increasing Use of Stem Cells in Regenerative Orthopedics Propels Manufacturing
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Stem Cell Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Stem Cell Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Culture Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Culture Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Culture Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 9: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 12: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Stem Cell Lines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Stem Cell Lines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 15: World 16-Year Perspective for Stem Cell Lines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Research-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Research-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 18: World 16-Year Perspective for Research-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Cell & Tissue Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Cell & Tissue Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 21: World 16-Year Perspective for Cell & Tissue Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Clinical-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Clinical-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 24: World 16-Year Perspective for Clinical-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 25: World Stem Cell Manufacturing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
  • TABLE 29: USA Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Canada Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: Canada 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: Canada 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
• JAPAN
  • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 38: Japan Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Japan Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: Japan 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
  • TABLE 41: Japan Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Japan Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: Japan 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
• CHINA
  • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 44: China Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: China Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: China 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
  • TABLE 47: China Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: China Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: China 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
• EUROPE
  • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Stem Cell Manufacturing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: Europe 16-Year Perspective for Stem Cell Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
  • TABLE 56: Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Europe Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: Europe 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
• FRANCE
  • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 59: France Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: France Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: France 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
  • TABLE 62: France Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: France Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 64: France 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
• GERMANY
  • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 65: Germany Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Germany Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 67: Germany 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
  • TABLE 68: Germany Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Germany Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 70: Germany 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 71: Italy Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Italy Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 73: Italy 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
  • TABLE 74: Italy Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Italy Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 76: Italy 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 77: UK Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 78: UK Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 79: UK 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
  • TABLE 80: UK Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 81: UK Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 82: UK 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 84: Rest of Europe Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 85: Rest of Europe 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
  • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Rest of Europe Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 88: Rest of Europe 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Asia-Pacific Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 91: Asia-Pacific 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
  • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Asia-Pacific Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 94: Asia-Pacific 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Rest of World Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 97: Rest of World 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
  • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Rest of World Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 100: Rest of World 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030

IV. COMPETITION